The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenincode Share News (GENI)

Share Price Information for Genincode (GENI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.375
Bid: 6.25
Ask: 6.50
Change: 0.25 (4.08%)
Spread: 0.25 (4.00%)
Open: 6.125
High: 6.375
Low: 6.125
Prev. Close: 6.125
GENI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS: ASA interim profit plummets; Mycelx loss narrows, revenue up

Wed, 20th Sep 2023 16:24

(Alliance News) - The following is a round-up of earnings of London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

ASA International Group PLC - Weybridge, Surrey-based microfinance lender - Pretax profit in the first half of 2023 falls to USD13.8 million from USD46.3 million a year earlier. Number of branches increases to 2,073 from 2,028, while number of clients as at June 30 declines to 2.2 million from 2.3 million. Says lower profit partly due to lower recovery of overdue loans in India. Raises expected credit losses charge to USD2.8 million from USD1.9 million a year prior. Looking ahead, expects improvement in the second half but eyes 2023 net profit to be lower than 2022. Further, giving an August update, says gross outstanding loan portfolio fell annually by 5% to USD352 million.

----------

GENinCode PLC - biotechnology company focused on prevention of cardiovascular disease - In the first half of 2023, pretax loss widens to GBP3.5 million from GBP2.3 million year prior. Revenue rises 43% to GBP950,000 from GBP664,000. Administrative expenses however increase 50% to GBP3.8 million from GBP2.6 million. Cash reserves as at June 30 fall annually to GBP5.2 million from GBP12.4 million. Chief Executive Officer Matthew Walls says: "Growing test demand from UK and EU markets and the launch of the US Early Access Program has begun to strengthen business revenues and our forecast growth outlook. We are working closely with our US partner institutions on commercial scale-up and delivery of our Early Access Programs to generate our first US revenues whilst progressing our CIC SCORE 510k medical device pre-market submission in readiness for approval."

----------

HydrogenOne Capital Growth PLC - London-based hydrogen technology investment fund - Net asset value per share as at June 30 grows to 100.70 pence from 97.31p as at December 31, citing clean hydrogen opportunities. NAV total return is 3.5%. Chair Simon Hogan says: "The board and company is committed to the aim of the company that seeks to generate NAV returns of 10-15% over time, including proceeds from exits, whilst investing in clean hydrogen for a climate positive impact." Looking ahead, he says: "Overall, despite the uncertainty of the current economic environment, the board remains confident that the company is investing in a sector with a favourable outlook and believes in its growth potential as illustrated by the strength of our current pipeline of private clean hydrogen investments."

----------

Mycelx Technologies Corp - Georgia, US-based clean water and air technology company - Reports pretax loss of USD1.3 million, narrowed from USD2.7 million a year prior. Revenue climbs to USD5.6 million from USD3.7 million. However, cost of goods sold increases to USD3.1 million from USD2.3 million. Looking ahead, Chair Tom Lamb and Chief Executive Officer Connie Mixon say: "The momentum shown in the first half from each of our three core markets has been maintained into the current period and we are confident that this will continue for the forseeable future. The PFAS remediation market is large and will continue for years to come. Regulations continue to get more stringent, and more sites will be identified over time. In the short and medium term our goal is to both win new contracts and to acquire solid data through trials with significant longevity, building relationships with strategic partners and direct customers that will accelerate uptake of our PFAS solution."

----------

Prospex Energy PLC - Europe-focused gas and power project investor - In the six months to June 30, turns to loss of GBP1.0 million from a profit of GBP7.0 million a year prior. Reports loss on revaluation of investments and loans of GBP489,037 compared to a gain of GBP7.6 million a year earlier. Looking ahead, Chair Bill Smith says: "The board and management continues to focus on developing and growing the company's portfolio of assets and income streams, both by increasing the productivity and profitability of existing assets, and through active search and investigation of new investment opportunities which meet the company's discerning investment criteria."

----------

Tavistock Investments PLC - Bracknell, England-based investment manager - In the financial year to March 31, turns to pretax loss of GBP1.6 million from profit of GBP30.0 million a year prior. Revenue is virtually unchanged. However, company had a one-off gain from the sale of subsidiary Tavistock Wealth of GBP35.8 million in financial 2022. Looking ahead, Chair Oliver Cooke says company is now ready to operate "on a much larger scale" and is on the next phase of its growth plan.

----------

By Tom Budszus, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
23 Mar 2022 15:31

GENinCode inks collaboration with largest US medical school

(Sharecast News) - Cardiovascular genetics company GENinCode announced a collaboration with the Indiana University School of Medicine (IU) on Wednesday - the largest medical school in the United States.

Read more
15 Mar 2022 19:45

TRADING UPDATES: Hyve exits Russia; Genel revenue rises in 2021

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
15 Mar 2022 13:35

GENinCode enters cholesterol collaboration with Cumbria health network

(Sharecast News) - Cardiovascular genetics company GENinCode announced a collaboration with the Academic Health Science Network for the North East and North Cumbria (AHSN NENC) on Tuesday, to pilot the use of its 'Lipid inCode' test for the diagnosis of high cholesterol - hypercholesterolemia - and familial hypercholesterolemia (FH).

Read more
8 Feb 2022 20:35

IN BRIEF: GENinCode Lipid inCode test sees strong results in NHS probe

IN BRIEF: GENinCode Lipid inCode test sees strong results in NHS probe

Read more
8 Feb 2022 15:37

GENinCode reports success in NHS trial of cholesterol test

(Sharecast News) - Predictive genetics technology company GENinCode announced on Tuesday the successful completion of its NHS clinical study, and positive results for its 'Lipid inCode' test for high cholesterol, including familial hypercholesterolemia (FH), undertaken at Royal Brompton and Harefield Hospitals.

Read more
10 Jan 2022 14:44

IN BRIEF: GENinCode FDA presubmission for cardiovascular disease test

IN BRIEF: GENinCode FDA presubmission for cardiovascular disease test

Read more
29 Nov 2021 14:33

EXECUTIVE CHANGES: SIMEC and Feedback tap new chief financial officers

EXECUTIVE CHANGES: SIMEC and Feedback tap new chief financial officers

Read more
25 Nov 2021 12:13

TRADING UPDATES: Raft of London-listed firms raise 2021 outlook

TRADING UPDATES: Raft of London-listed firms raise 2021 outlook

Read more
25 Nov 2021 11:36

Genincode moving towards 'a number of important milestones'

(Sharecast News) - Predictive genetics company Genincode said on Thursday that it was now moving towards "a number of important milestones" which will drive its growth and profile over the coming years.

Read more
16 Sep 2021 17:18

TRADING UPDATES: Schroder Asian, AVI Japan both outperform benchmarks

TRADING UPDATES: Schroder Asian, AVI Japan both outperform benchmarks

Read more
9 Sep 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
26 Jul 2021 19:23

TRADING UPDATES: Esken gives up Teeside deal; Kanabo buys in Europe

TRADING UPDATES: Esken gives up Teeside deal; Kanabo buys in Europe

Read more
23 Jul 2021 14:41

IN BRIEF: Downing One VCT assets up after GENinCode float on AIM

IN BRIEF: Downing One VCT assets up after GENinCode float on AIM

Read more
22 Jul 2021 19:15

GENinCode shares slip on first day of dealings in London

GENinCode shares slip on first day of dealings in London

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.